Aardvark Therapeutics, Inc. (AARD) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Aardvark Therapeutics, Inc. (AARD) closed at USD 3.88 on 2026-10-14, a change of -67.7 % over the past year, with a market capitalization of USD 84.48M.

Aardvark Therapeutics, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Aardvark Therapeutics, Inc. key figures

Previous close

USD 3.88 (2026-10-14)

1-year change

-67.7 %

Market cap

USD 84.48M

Enterprise value

USD 11.28M

P/E ratio (trailing)

-1.25

P/E ratio (forward)

-1.62

EPS (trailing)

-3.10

EPS (forward)

-2.38

PEG ratio

n/a

Price to book

1.13

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

3.93

Employees

28

Analyst consensus (third-party)

buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Aardvark Therapeutics, Inc.

Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Aardvark Therapeutics, Inc. and compare it with other stocks.